# HFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure

> **NCT02978300** · NA · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 300 (actual)

## Conditions studied

- Acute Respiratory Failure
- Immunosuppression

## Interventions

- **DEVICE:** NIV/HFNC
- **DEVICE:** HFNC

## Key facts

- **NCT ID:** NCT02978300
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-21
- **Primary completion:** 2019-04-02
- **Final completion:** 2019-08-30
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02978300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02978300, "HFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02978300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*